Journal of Cutaneous Pathology · 2008 · 16 citations · 21 references
MedicineDermatologyPathologyApoptosisCutaneous OncologyPhotodermatologyApoptosis In CancerApoptosis RegulationApoptotic SignalingBasal Cell CarcinomaPhotodynamic TherapyApoptotic ResponseApoptotic UltrastructureDermatologic Photodynamic TherapyEarly Apoptotic MarkersMonocyte Chemoattractant Protein-1Stem Cell Factor SignalingSuperficial Basal Cell CarcinomaVascular Endothelial Growth Factor
BACKGROUND: Photodynamic therapy (PDT) of superficial basal cell carcinoma (SBCC) acts as a biological response modifier or killing target cells, but sequential biological effects have not been reported in depth in humans. METHODS: In 15 patients with SBCC treated with aminolevulinic acid (ALA)-PDT, inflammatory infiltrate, apoptosis phenomena and tumor-derived molecules were investigated on biopsies at baseline, and after 15 min and 4, 24, 48 and 72 h, by immunohistochemistry and ultrastructure. RESULTS: Early apoptosis of keratinocytes was already observed at 15 min, while late apoptotic markers were maximally found at 24 h. Baseline mast cells tended to slightly increase up to 72 h; polymorphonuclear phagocytes significantly increased at 4 h but decreased at 24/48/72 h; on the contrary, lymphocytes and macrophages gradually increased starting at baseline. At baseline, SBCC cells expressed stem cell factor in all cases, and granulocyte-monocyte colony-stimulating factor, basic fibroblastic growth factor, interleukin (IL)-8 and vascular endothelial growth factor in most cases. IL-6 and monocyte chemoattractant protein-1 were poorly expressed, and transforming growth factor-beta was absent. CONCLUSIONS: We show a clear time-dependent profile of apoptotic markers and inflammatory infiltrate composition in SBCC after ALA-PDT. SBCC cells express cytokines and chemotactic molecules that are likely related to the recruitment of inflammatory cells.
21
Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Angela Ferrario, K F von Tiehl, Natalie Rucker et al. · PubMed · 2000 · 256 citations
Medicine, Oncology, Pharmacology +17
Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo.
Sandra O. Gollnick, Liu X, Barbara Owczarczak et al. · PubMed · 1997 · 223 citations
Life Sciences, Immunology, Oncology +17
M Rampart, Jo Van Damme, L Zonnekeyn et al. · PubMed · 1989 · 151 citations
Medicine, Immunology, Pathology +14